<Anchor> The Korean

government has begun collecting information on Russian vaccines. This is to determine whether it is introduced in Korea, and the key is how much safety can be secured.

This is reporter Kim Deok-hyun.

<Reporter> The

Ministry of Foreign Affairs recently received a request from the Ministry of Food and Drug Safety, and began to collect safety information, that is, cases of adverse reactions after vaccination with Sputnik V vaccine.

Consulates in 12 countries, including Russia, that are vaccinating the vaccine, have already given relevant instructions.

The Sputnik V vaccine was developed by Russia in August of last year.

Two shots every three weeks are the same as Pfizer vaccine, and adenovirus as a carrier is the same as AstraZeneca and Janssen vaccines.

Although there was controversy over water vaccines in the early stages of development, in February, a global academic journal lancet received attention for the interim results of phase 3 clinical trials with a preventive effect of 91.6%.

There are 60 countries that have approved the use of the vaccine, and no application has been made in Korea.

The European Medicines Agency launched an approval review last month, and the availability and timing of the approval depend on how accurate and sufficient data were submitted.

[Jungki Kim/Professor of Korea University College of Pharmacy: I need data on cases of (vaccination). Russia is not properly disclosing this part. There is a very difficult part to verify.]

There is no global supply shortage like Pfizer, Moder or Vaccine, but domestic companies are commissioned to produce more than 100 million batches starting next month.

Although it is for export, having a domestic production facility can help to secure the quantity.